Home
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- Top GNC Executives Tour Chicago Market to Present New Business Plan and Expansion Possibilities; Meeting Will Focus On New Business Strategies and Growth
- Genentech Named One of Fortune's '100 Best Companies to Work For'; Biotechnology Industry Leader Named to List for Fourth Consecutive Year
- Perrigo Company Reports Second Quarter Fiscal 2002 Earnings of $0.22 Per Share
- NBTY Reports Record First Quarter Sales & Net Income Wholesale Sales Up 66%
- Leiner Health Products Appoints Robert Reynolds as Chief Financial Officer
- Leiner Health Products Appoints Robert Reynolds as Chief Financial Officer
- Cyanotech Japan YK Formed to Service Growing Market Demand
- Cyanotech Japan YK Formed to Service Growing Market Demand
- Cyanotech Japan YK Formed to Service Growing Market Demand
- Natural Health Trends Corp. Enters Caribbean Market;
- Natural Health Trends Corp. Enters Caribbean Market;
- Nutrition 21 Names Eric W. Klar as Business Director of Its Consumer Products Operations
- Nutrition 21 Names Eric W. Klar as Business Director of Its Consumer Products Operations
- Phytomedics Inc. and Degussa AG Enter Strategic Collaboration
- Phytomedics Inc. and Degussa AG Enter Strategic Collaboration
- Imperial Ginseng Products Ltd. Reports Second Quarter 2002 Fiscal Year Results
- UK's Luscious Organic and Low Fat Launches Bid for Third Round Funding To Go Global.
- UK's Luscious Organic and Low Fat Launches Bid for Third Round Funding To Go Global.
- UK's Luscious Organic and Low Fat Launches Bid for Third Round Funding To Go Global.
- UK's Luscious Organic and Low Fat Launches Bid for Third Round Funding To Go Global.
- Natrol, Inc. Announces $20 Million Write Down of Goodwill
- Nature's Sunshine Products Reports Fourth Quarter and Year End Results
- Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium
According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer.
- Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium
According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer.
- Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium
According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer.
- ON's Pro Complex® Augmented Protein System Goes Natural
- ON's Pro Complex® Augmented Protein System Goes Natural
- ON's Pro Complex® Augmented Protein System Goes Natural
- ON's Pro Complex® Augmented Protein System Goes Natural
- ON's Pro Complex® Augmented Protein System Goes Natural
- Trace Minerals Research Releases New and Improved Performance Electrolyte Formula
Trace Minerals Research is now offering a new and improved formula of Electrolyte Stamina Tablets, an electrolyte replacement supplement designed for individuals that expend large amounts of electrolytes during strenuous activities. Electrolyte Stamina Tablets now contain P-5-P and L-Taurine.
- Trace Minerals Research Releases New and Improved Performance Electrolyte Formula
Trace Minerals Research is now offering a new and improved formula of Electrolyte Stamina Tablets, an electrolyte replacement supplement designed for individuals that expend large amounts of electrolytes during strenuous activities. Electrolyte Stamina Tablets now contain P-5-P and L-Taurine.
- Trace Minerals Research Releases New and Improved Performance Electrolyte Formula
Trace Minerals Research is now offering a new and improved formula of Electrolyte Stamina Tablets, an electrolyte replacement supplement designed for individuals that expend large amounts of electrolytes during strenuous activities. Electrolyte Stamina Tablets now contain P-5-P and L-Taurine.
- Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3
Natural Nutrition, Inc., has reported net income of $2,062,452 (unaudited) for the first nine months of 2008 through September 30th versus losses of $3,744,404 through the same first nine months of 2007. These numbers are unaudited and subject to revision.
- Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3
Natural Nutrition, Inc., has reported net income of $2,062,452 (unaudited) for the first nine months of 2008 through September 30th versus losses of $3,744,404 through the same first nine months of 2007. These numbers are unaudited and subject to revision.
- Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3
Natural Nutrition, Inc., has reported net income of $2,062,452 (unaudited) for the first nine months of 2008 through September 30th versus losses of $3,744,404 through the same first nine months of 2007. These numbers are unaudited and subject to revision.
- Nutraceutical Reports FY08 End Results
Nutraceutical International Corporation has announced the results for the fiscal 2008 fourth quarter and year ended September 30, 2008. Net sales for the fiscal year ended September 30, 2008 were $166.9 million compared to $156.5 million for fiscal 2007. For fiscal 2008, net income was $11.9 million (including the $1.8 million goodwill impairment charge), or $1.07 diluted earnings per share (including the goodwill impairment charge of $0.16 per share), compared to net income of $13.0 million (including the $0.3 million intangible asset impairment charge), or $1.15 diluted earnings per share (including the intangible asset impairment charge of $0.02 per share), for fiscal 2007.
- Nutraceutical Reports FY08 End Results
Nutraceutical International Corporation has announced the results for the fiscal 2008 fourth quarter and year ended September 30, 2008. Net sales for the fiscal year ended September 30, 2008 were $166.9 million compared to $156.5 million for fiscal 2007. For fiscal 2008, net income was $11.9 million (including the $1.8 million goodwill impairment charge), or $1.07 diluted earnings per share (including the goodwill impairment charge of $0.16 per share), compared to net income of $13.0 million (including the $0.3 million intangible asset impairment charge), or $1.15 diluted earnings per share (including the intangible asset impairment charge of $0.02 per share), for fiscal 2007.
- Nutraceutical Reports FY08 End Results
Nutraceutical International Corporation has announced the results for the fiscal 2008 fourth quarter and year ended September 30, 2008. Net sales for the fiscal year ended September 30, 2008 were $166.9 million compared to $156.5 million for fiscal 2007. For fiscal 2008, net income was $11.9 million (including the $1.8 million goodwill impairment charge), or $1.07 diluted earnings per share (including the goodwill impairment charge of $0.16 per share), compared to net income of $13.0 million (including the $0.3 million intangible asset impairment charge), or $1.15 diluted earnings per share (including the intangible asset impairment charge of $0.02 per share), for fiscal 2007.
- Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition
Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France.
- Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition
Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France.
- Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition
Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France.
- Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition
Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France.
- Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition
Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France.
- Lifeway Foods Announces New West Coast Distribution
Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008.
- Lifeway Foods Announces New West Coast Distribution
Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008.
- Lifeway Foods Announces New West Coast Distribution
Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008.
- Lifeway Foods Announces New West Coast Distribution
Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008.
- Lifeway Foods Announces New West Coast Distribution
Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008.
- Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients
Symrise has acquired licenses for two new groups of cosmetic active ingredients. These promising results were achieved in a joint development project with biotech specialist BRAIN and natural-product company AnalytiCon. The license gives Symrise international marketing rights.
- Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients
Symrise has acquired licenses for two new groups of cosmetic active ingredients. These promising results were achieved in a joint development project with biotech specialist BRAIN and natural-product company AnalytiCon. The license gives Symrise international marketing rights.
- Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients
Symrise has acquired licenses for two new groups of cosmetic active ingredients. These promising results were achieved in a joint development project with biotech specialist BRAIN and natural-product company AnalytiCon. The license gives Symrise international marketing rights.
- Mannatech Declares Dividend
Mannatech, Incorporated has announced that its Board of Directors declared a quarterly cash dividend on Wednesday, November 19, 2008 of $0.02 per share of common stock payable on Monday, December 29, 2008, to shareholders of record at the close of business on Thursday, December 11, 2008.
- Mannatech Declares Dividend
Mannatech, Incorporated has announced that its Board of Directors declared a quarterly cash dividend on Wednesday, November 19, 2008 of $0.02 per share of common stock payable on Monday, December 29, 2008, to shareholders of record at the close of business on Thursday, December 11, 2008.
- Mannatech Declares Dividend
Mannatech, Incorporated has announced that its Board of Directors declared a quarterly cash dividend on Wednesday, November 19, 2008 of $0.02 per share of common stock payable on Monday, December 29, 2008, to shareholders of record at the close of business on Thursday, December 11, 2008.
- NPI Daily - Top of The News for November 20, 2008 - Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment
Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients; Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3; Nutraceutical Reports FY08 End Results; Mannatech Declares Dividend; Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition; Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium; Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment; PC Brands Introduces Shelf-Stable Nutrition Bar With Probiotics; Lifeway Foods Announces New West Coast Distribution; Trace Minerals Research Releases New and Improved Performance Electrolyte Formula
- NPI Daily - Top of The News for November 20, 2008 - Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment
Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients; Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3; Nutraceutical Reports FY08 End Results; Mannatech Declares Dividend; Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition; Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium; Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment; PC Brands Introduces Shelf-Stable Nutrition Bar With Probiotics; Lifeway Foods Announces New West Coast Distribution; Trace Minerals Research Releases New and Improved Performance Electrolyte Formula
|
Reduces Interest from Conversion of Health Holdings & Botanicals Debt;
Extends Loan Agreement with Wells Fargo Business Credit
IRVINE, Calif. -- Naturade, Inc. (OTCBB: NRDC), a leading marketer of soy protein products under the Naturade Total Soy(TM) brand name, today received $2.5 million of capital from Westgate Equity Partners, L.P. (Westgate) of St. Louis, in a transaction that provides working capital to build the Naturade Total Soy brand and support continued strong revenue growth.
In simultaneous transactions, Health Holdings & Botanicals, LLC (HHB) agreed to convert its $5.3 million of Naturade debt to common stock. In addition, Wells Fargo Business Credit (Wells) agreed to extend the existing Credit and Security Agreement through December 31, 2003. The recapitalization resulting from these transactions will significantly improve Naturade's balance sheet and financial ratios.
Naturade CEO Bill Stewart said, "The financial strength of our new partnership with Westgate will allow us to intensify our focus on brand-building as the No. 1 brand of soy protein meal replacements in the mass market and to maintain our reputation as innovators of natural products that offer real consumer health benefits. Westgate recognizes our potential, which is supported by the FDA approved heart health claim for soy protein, and understands the value of our distribution base in 28,000 mass market outlets. We also are excited by their interest in creating additional strategic alliances for Naturade."
In consideration of its investment, Westgate received shares of redeemable preferred stock convertible into 13,540,723 shares of common stock (subject to adjustment to protect against dilution) and a three-year warrant to purchase, for $3.5 million, additional shares of redeemable preferred stock convertible into 33,641,548 shares of common stock that would raise Westgate's ownership to 51%. In consideration of its conversion of Naturade's debt and cancellation of its preferred shares, HHB received 35,989,855 shares of common stock. Currently, there are 43,813,494 shares of common stock outstanding.
Naturade has agreed to elect two Westgate representatives to its board of directors. Form 8-K filed with the Securities and Exchange Commission provides a description of the rights of the preferred shares sold to Westgate and the terms of the transactions with Westgate, HHB and Wells.
Westgate is a $120 million, consumer-oriented committed equity fund whose principals offer particular expertise in natural, soy protein-based products. Its investors include the nation's largest independent pension system, numerous financial institutions and high net worth executives. William P. Stiritz, Westgate's chairman and organizer, is the former chief executive officer of Ralston Purina Company, which, until 1997, was the parent company of Protein Technologies International, Inc. (PTI).
PTI, now a division of DuPont, is the world's leading supplier of soy protein isolate raw material and a strategic partner with Naturade, supplying raw material, cooperative marketing support and research and development assistance. Jay Brown, who is responsible for operational oversight of Westgate's portfolio companies, will play a key role in supporting Naturade expansion efforts. Brown worked closely with Stiritz at Ralston Purina where he served as CEO of Van Camp Seafood Company, Continental Baking Company and PTI.
Brown said, "We believe strongly in the long-term growth potential for soy protein products and see Naturade as a solid base from which to build brands that merit high consumer purchase interest and strong retailer support. We have high confidence in the consumer packaged goods experience of the Naturade management team and in the scientific studies that support the Company's key product claims."
The Wells agreement is an amendment to an existing business relationship begun in January 2000 through which Naturade maintains a secured line of credit that contains certain financial and other covenants, as well as restrictions on the payment of dividends and other distributions. It includes a security interest in the equipment, inventory, receivables and other assets of Naturade.
Headquartered in Irvine, Calif., Naturade -- since 1926 -- has been committed to marketing innovative natural products that nourish the health and well-being of consumers. Well-known for its 50 years of leadership in soy protein, Naturade is the number one brand name sold in food, drug and mass merchandise stores. Its premier product, Naturade Total Soy, is a complete line of ready-to-drink, bars and shake mix meal replacement products sold at more than 33,000 supermarkets and drug, health food and mass merchandise stores. The Company's other products include, Ribo-tein(TM), Naturade Organic Soy(TM), Naturade NRG(TM), Naturade Veg(TM), Naturade 100% Soy(TM) and Aloe Vera 80(R) beauty care products. For more information, visit the Naturade Web site at www.naturade.com or call toll-free (877)4 Soy News.
NOTE: THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES A "SAFE HARBOR" FOR CERTAIN FORWARD-LOOKING STATEMENTS. THE STATEMENTS CONTAINED IN THIS NEWS RELEASE THAT ARE NOT HISTORICAL FACTS ARE FORWARD-LOOKING STATEMENTS BASED ON THE COMPANY'S CURRENT EXPECTATIONS AND BELIEFS CONCERNING FUTURE DEVELOPMENTS AND THEIR POTENTIAL EFFECTS ON THE COMPANY. THERE CAN BE NO ASSURANCE THAT FUTURE DEVELOPMENTS AFFECTING THE COMPANY WILL BE THOSE ANTICIPATED BY THE COMPANY. ACTUAL RESULTS MAY DIFFER FROM THOSE PROJECTED IN THE FORWARD-LOOKING STATEMENTS. THESE FORWARD-LOOKING STATEMENTS INVOLVE SIGNIFICANT RISKS AND UNCERTAINTIES (SOME OF WHICH ARE BEYOND THE CONTROL OF THE COMPANY) AND ARE SUBJECT TO CHANGE BASED UPON VARIOUS FACTORS. THESE FACTORS INCLUDE THE IMPACT OF FEDERAL REGULATIONS GOVERNING THE SALE OF THE COMPANY'S PRODUCTS, LESS THAN EXPECTED CONSUMER DEMAND FOR THE COMPANY'S PRODUCTS, PRICING PRESSURES AND OTHER COMPETITIVE FACTORS. THE COMPANY UNDERTAKES NO OBLIGATION TO PUBLICLY UPDATE OR REVISE ANY FORWARD-LOOKING STATEMENTS, WHETHER AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE. FOR A MORE DETAILED DISCUSSION OF SOME OF THE ONGOING RISKS AND UNCERTAINTIES OF THE COMPANY'S BUSINESS, SEE THE COMPANY'S FILINGS WITH THE SECURITIES AND EXCHANGE COMMISSION.
CONTACT: Naturade, Inc.
John Hazlin, 714/573-4800, Ext. 221
or
Mark Grody Associates
Mark Grody, 760/674-8012
|